Interview by DermTalks
DermTalks is a project led with a board of dermatologists and intended to address current challenges, data gaps and emerging trends in dermatology across North-European countries.

Speaker: Prof. Mette Deleuran, Associate Professor and Chair of the Department of Dermatology and Venereology, Aarhus University Hospital, Denmark.

In this episode of Polyp Gossip, we explore the power of personalized care in CRSwNP. From symptoms to patient profiles, our experts discuss how tailored treatment strategies can lead to better outcomes and improved quality of life. Tune in to discover what "finding what works best for you" really means in today's evolving care landscape.

In this episode we explore the critical decision of whether surgery is the right choice for CRSwNP patients. Leading experts discuss the factors influencing surgical vs. medical management, patient considerations, and the latest advancements in treatment. Tune in for an in-depth look at this big decision in CRSwNP care!

In this episode of Polyp Gossip, we dive into the real-life experiences of patients living with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), exploring how the condition impacts their daily routines, relationships, and overall well-being. Our guests share their journeys, shedding light on the emotional and physical toll of the condition.

We explore the impact of smell impairment and its connection to CRSwNP. Featuring insights from our hosts and a special guest, we uncover pathways to recovery and improved quality of life.

Welcome to the debut episode of Polyp Gossip! In this episode, our expert panel explores a critical question in CRSwNP management: Is one surgery enough before starting biologics?

The Type 1 Diabetes (T1D) field is evolving.

Recognition of the presymptomatic stages in T1D is growing.^1-4 

The clinical benefits of early detection of T1D are being highlighted.^3-4 Programmes focusing on early detection through testing and screening for presymptomatic autoimmune T1D are increasingly offered to risk populations and the general population.^1,2

Autoimmune Type 1 diabetes (T1D) is undergoing a fundamental transformation in how the medical community approaches diagnosis and care.

Sanofis symposium under Svenska Lungkongressen 2026 i Norrköping.